Markets›VRAX

Virax Biolabs Group Ltd

VRAX
2.40
-0.04 (-1.84%)
Closing price for Sep 25, 2026 from Polygon.io

What Virax Biolabs Group Ltd does

No written description is available right now. The company's annual report on the SEC filings tab describes its business in detail.

Key facts

IndustryIn Vitro & In Vivo Diagnostic Substances
HeadquartersLANARKSHIRE, X0
Incorporated inE9
Listed onNasdaq
Fiscal year endsMarch 31
SEC filer categoryNon-accelerated filer<br>Emerging growth company
SEC company number (CIK)1885827

Company description from Polygon.io. Industry, address and filing details from SEC EDGAR.